Long-term potentiation (LTP) in the hippocampus is a possible mechanism for mammalian learning and memory in which protein kinases play critical roles. We have investigated the involvement of cyclic AMP-dependent protein kinase (PKA) in LTP by directly studying its activation. We developed an in vitro assay which is useful for selective and accurate measurement of stimulusinduced changes in PKA activity in hippocampal slices. PKA was transiently activated 2 and 10 min after delivery of LTP-inducing stimuli in area CA1 of the hippocampus. This activation did not persist during early or late phases of LTP, suggesting that the role of PKA is in the induction of LTP, not in its expression. LTP was not associated with any change in the total activity of PKA, consistent with activation by cyclic AMP, as opposed to an increase in the amount or efficacy of the enzyme. The LTP-associated activation of PKA required stimulation of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptor, and bath application of NMDA was sufficient to activate PKA. Together, these results indicate that at the initiation of LTP, NMDA receptor stimulation leads to transient activation of PKA, and support a role for PKA in the induction of LTP.
Most modern theories of learning and memory postulate that the basis of information storage in the brain is modulation of the strength of synaptic connections between neurons. With an eye toward understanding the molecular mechanisms of memory, we and others have begun to dissect the mechanisms underlying long-term potentiation (LTP) 1 in the hippocampus. In LTP, very brief stimuli produce a persistent increase in the efficacy of a group of synapses; this phenomenon may be involved in mammalian learning and memory.
A key insight into the molecular basis of LTP was the discovery that protein kinases are critically involved in both its induction and expression (1) . In recent years, many different kinases have been implicated in LTP (reviewed in Ref. 2) , including the cyclic AMP-dependent protein kinase (PKA; reviewed in Ref. 3) . The current understanding of PKA's role in LTP, though, is poor, and much of the confusion pertains to the nature of PKA's involvement in different phases of LTP. LTP has an initial phase (I-LTP, also known as short-term potentiation) lasting approximately 30 min that is insensitive to most protein kinases inhibitors, a protein kinase-dependent early phase (E-LTP) that lasts until 3-4 h after induction, and an ensuing late phase (L-LTP) distinguished by a requirement for RNA and protein synthesis at the time of the inducing stimulus.
It is known that levels of cyclic AMP, the second messenger activator of PKA, rise immediately after the initiation of LTP (4) and return to resting levels over the next 10 -20 min (5). Cell-permeant inhibitors of PKA, however, have a somewhat unexpected effect. These inhibitors, when applied during the early elevation of cyclic AMP, completely block L-LTP, a phase which would not begin for several hours (6 -8) . PKA inhibitors also attenuate E-LTP, although the effect is variable. One study found little effect of cell-permeant PKA inhibitors on E-LTP (7), while others, using the same inhibitors at higher concentrations, found that they reduced the magnitude of E-LTP (6, 8) . Finally, when PKA inhibitors were injected directly into the postsynaptic cell, likely producing even higher effective concentrations, they completely blocked both I-LTP and E-LTP (9) .
These studies raise important questions, such as the following. How is the initial increase in cyclic AMP parlayed into the production of L-LTP? Cyclic AMP could support L-LTP by begetting persistent activation of PKA, much as in long-term sensitization in Aplysia (10 -12) . On the other hand, it may cause transient activation of PKA, which could support L-LTP by initiating a cascade of events. The ability to answer this question as well as those about PKA's role in E-LTP is hindered by the fact that the dynamics of PKA activation during LTP are not understood. The goal of the present study is to improve our grasp of PKA's role in LTP by directly examining its activation.
EXPERIMENTAL PROCEDURES
Hippocampal Slice Preparation and Electrophysiology-The hippocampi of 4 -8-week-old, male, Sprague-Dawley rats were removed and briefly chilled in ice-cold cutting saline (110 mM sucrose, 60 mM NaCl, 3 mM KCl, 1.25 mM NaH 2 PO 4 , 28 mM NaHCO 3 , 0.5 mM CaCl 2 , 7 mM MgCl 2 , 5 mM D-glucose, 0.6 mM ascorbate, saturated with 95% O 2 , 5% CO 2 ). Slices 400 m thick were prepared with a Vibratome and maintained at room temperature for at least 45 min in a holding chamber containing 50% recording saline (125 mM NaCl, 2.5 mM KCl, 1.24 mM NaH 2 PO 4 , 25 mM NaHCO 3 , 10 mM D-glucose, 2 mM CaCl 2 , 1 mM MgCl 2 , saturated with 95% O 2 , 5% CO 2 ) and 50% cutting saline. Slices were transferred to a Fine Science Tools interface recording chamber and equilibrated at 32°C in recording saline for at least 45 min. Electrophysiological recordings were conducted essentially as described previously (4) . Briefly, test stimuli were delivered to the Schaffer collateral/ commissural pathway in area CA1 with a bipolar Teflon-coated platinum electrode at 0.05 Hz. Responses were recorded in stratum radiatum with an extracellular glass microelectrode. LTP was induced * This work was supported by National Institutes of Health Grant MH48186 (to J. D. S.) and a Life and Health Insurance Medical Research Fund Young Scientist M.D./Ph.D. Scholarship (to E. D. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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after at least 20 min of stable baseline recording by three sets of stimuli at 10-min intervals, each set consisting of three 1-s, 100-Hz tetani, 5 s apart at a stimulus intensity which produced a population excitatory postsynaptic potential (pEPSP) approximately 75% of maximum. In single tetanus experiments, one 1-s, 100-Hz tetanus was delivered at a stimulus intensity which produced a pEPSP approximately 25% of maximum. For pharmacological treatments, drugs were bath-applied by addition to the recording saline. In some cases, a small volume of concentrated drug was also injected directly into the chamber in order to produce a more rapid rise in concentration. Slices were removed from the chamber at the desired time point and frozen immediately on dry ice. Area CA1 was microdissected and stored at Ϫ80°C until assayed.
PKA Assay-Area CA1 subregions from individual hippocampal slices were briefly sonicated at low power, on ice, in 300 l of homogenization buffer (HB; 50 mM MES, pH 6.0, 1 mM EDTA, 1 mM EGTA, 2 mM ␤-mercaptoethanol, 0.01% Triton X-100, protease inhibitors: 10 g/ml leupeptin and 2 g/ml aprotinin, and phosphatase inhibitors: 2 mM Na 4 P 2 O 7 , 1 M microcystin-LR, and 200 nM calyculin A). In experiments using whole hippocampal homogenate, 1 rat hippocampus was homogenized in 2 ml of HB in a glass/Teflon motorized homogenizer. Kinase reactions were begun immediately (within 15 s) to minimize the reassociation of PKA's catalytic subunit with the regulatory subunit. Reactions took place in 50-l volumes containing 25 l of HB (i.e. all components of HB at a final concentration 50% of the above listed values), as well as (final concentrations): 10 mM Mg(C 2 H 3 O 2 ) 2 , 20 M ATP, 100 M Ro-20-1724 (phosphodiesterase inhibitor), ϳ3000 cpm/ pmol [␥- 32 P]ATP, and 500 M Leu-Arg-Arg-Ala-Ser-Leu-Gly (Kemptide) PKA substrate, with or without 10 M cyclic AMP, a saturating concentration (data not shown). Reactions were carried out at 30°C for 5 min and stopped with 25 l of ice-cold stop solution (225 mM H 3 PO 4 and 1 mM ATP). Aliquots were spotted onto duplicate Whatman P-81 phosphocellulose paper strips, washed in 75 mM H 3 PO 4 for 2-4 h, rinsed in methanol, and dried. 32 P incorporation into Kemptide was quantitated by liquid scintillation counting. Background, calculated for each sample from parallel reactions which did not contain Kemptide, was subtracted. Protein concentrations were determined by the Bradford method with bovine serum albumin as the standard. Reaction velocities were linear with regard to time and protein concentration, and much less than 5% of substrate was converted into product under the conditions used (data not shown). In control slices, the average basal activity was 0.335 Ϯ 0.023 pmol/min/g, total activity was 2.432 Ϯ 0.154 pmol/ min/g, and the activity ratio of basal to total activity was 0.136 Ϯ 0.003 (n ϭ 67).
Data Analysis-The GraphPad Prism software package was used for curve-fitting and statistical analyses. Errors and error bars represent standard error of the mean.
Materials-Type I and Type II PKA purified from rabbit muscle were purchased from Sigma, as were Kemptide, PKI, myelin basic protein, forskolin, and NMDA. KT5823 was obtained from Calbiochem, activated MAPK from Stratagene, and APV from Cambridge Research Biochemicals. Peptides were synthesized at the Baylor College of Medicine Protein Chemistry Facility.
RESULTS
Our first goal was to develop an assay that would enable us to measure PKA activity in hippocampal slices. We chose to quantitate phosphorylation in vitro of an exogenous substrate to avoid the equivocality that arises with endogenous substrates due to prior phosphorylation in situ. We used Kemptide, a heptapeptide which is a highly potent and efficacious PKA substrate (13) . PKA activity was measured both in the absence of added cyclic AMP, which we refer to as basal activity, and in the presence of saturating cyclic AMP, which we term total activity. As basal activity is a measure of the amount of already active PKA in the homogenate and total activity is a measure of all PKA, determination of the "activity ratio" of basal to total activity provides a measure of the percentage of PKA in the active state (14) .
Selective Measurement of PKA-As we began our assays within seconds of homogenization to minimize the reassociation of PKA's catalytic and regulatory subunits, other protein kinases were present in the crude homogenates, and it was important to verify that the use of Kemptide and choice of reaction conditions were sufficient for selective detection of PKA. We were especially concerned about the other multifunctional serine/threonine kinases present in hippocampal homogenates which have been implicated in LTP, namely protein kinase C (PKC), calcium/calmodulin-dependent protein kinase II (CaMKII), cyclic GMP-dependent protein kinase (PKG), and p42 mitogen-activated protein kinase (MAPK).
We first demonstrated that the kinase activity detected in the assay had the cardinal property of PKA: cyclic AMPdependence. As expected, cyclic AMP produced a concentrationdependent increase in the activity in whole hippocampal homogenates (data not shown). The EC 50 of cyclic AMP for stimulation of PKA was approximately 0.11 M, in line with earlier estimates in other tissues (15) .
We next examined the ability of selective protein kinase inhibitors to block the observed activity in whole hippocampal homogenates. Two known PKA inhibitors, the heat-stable Walsh inhibitor (PKI; Ref. 16 ) and a synthetic peptide derived from its sequence (IP 20 ; Ref. 17) , abolished both basal activity and total activity (data not shown). These results are not attributed to inhibition of other kinases, as at the concentrations used, IP 20 does not detectably affect the activity of PKC or CaMKII (18) and PKI does not inhibit PKG (19) .
We also examined the effects of selective inhibitors of other protein kinases on the observed activity (data not shown). PKC- (19 -36) , a selective inhibitor of PKC (18), had no significant effect on either the basal or total activity observed, as expected given the observation that PKC does not phosphorylate Kemptide (20) . In addition, a selective peptide inhibitor of CaMKII (CaMKII-(273-302); Ref. 21 ) had no effect on the observed activity. CaMKII-(273-302) was used in conjunction with PKC- (19 -36) as the former can be phosphorylated by PKC present in the homogenates. 2 The PKG inhibitor KT5823 also had no effect; this is consistent with the observation that these homogenates do not contain significant Kemptide-directed PKG activity. 3 Finally, we found that with our assay conditions, p42
MAPK did not significantly phosphorylate Kemptide, while in control experiments, it did phosphorylate a favored substrate, myelin basic protein (data not shown). Together, all of these data demonstrate that the activity of these other kinases cannot account for our results.
PKA Activation by Forskolin-Knowing that the assay was selective for PKA, the next step was to demonstrate its utility in quantifying in situ changes in PKA activity in a hippocampal slice. As mentioned above, in order to ensure that the equilibrium between association and dissociation of PKA subunits is not skewed toward activation of PKA, no steps are taken to prevent reassociation. It was thus critical to determine whether activation of PKA in the slice could be maintained through the homogenization and assay procedures.
To address this question, we examined the effects of the adenylyl cyclase activator forskolin on PKA in hippocampal slices. Forskolin, bath-applied at 50 M for 15 min, produced a robust increase in PKA activity ratio in area CA1 ( Fig. 1A ; 298.9 Ϯ 33.7% of control, n ϭ 4, p Ͻ 0.0005). As expected for activation of PKA by increased levels of cyclic AMP, the change in activity ratio was accounted for by an increase in basal activity (292.0 Ϯ 44.8% of control, n ϭ 4, p Ͻ 0.0005), while total activity did not change (97.1 Ϯ 9.0% of control, n ϭ 4). These observations indicate that manipulations expected to increase PKA activity in situ yield measurable changes in activity in vitro.
Accurate Measurement of in Situ Activity-Correlation of the PKA activity observed in our assay in vitro and the original state of the kinase in situ depends on the assumption that the homogenization procedure does not affect the activity of PKA. It is known that certain experimental conditions such as high concentrations of NaCl favor the dissociation of the catalytic subunit and thus activation of PKA (22) . In addition, it has been pointed out that homogenization in small volumes can yield high cyclic AMP concentrations in the homogenate that could artifactually activate PKA (23) . In order to avoid these problems, we designed our assay with no added NaCl and with vast dilution of endogenous cyclic AMP such that its levels after homogenization, calculated from radioimmunoassay data (4), would be below the threshold for stimulation of PKA.
In addition, we experimentally addressed the question of whether homogenization per se results in PKA activation, using the method of Palmer et al. (23) . The essence of this experiment is to homogenize stimulated tissue with a relatively high PKA activity ratio along with exogenous PKA holoenzyme having a low activity ratio; this mixed sample is then compared with samples of the stimulated tissue alone and the exogenous kinase alone. Two possible outcomes of this experiment can be predicted. If the activation observed in vitro were artifactual, then the exogenous kinase would be activated to the same extent as the endogenous kinase, and the mixture would have an activity ratio similar to the stimulated tissue alone; we term this the "artifact prediction." On the other hand, if the activation observed in vitro provided an accurate assessment of PKA's state in situ, then one predicts that the exogenous kinase would not be activated, and that the activity ratio of the mixture would be a weighted average of the activity ratio of the stimulated tissue and the exogenous kinase; we refer to this as the "accurate prediction."
We used area CA1 subregions of hippocampal slices treated with 400 M NMDA as the stimulated tissue. This treatment provokes a large increase in cyclic AMP concentration in area CA1 (4, 5) , thus providing a stringent test of the hypothesis that endogenous cyclic AMP does not artifactually activate PKA upon homogenization; it also mimics the LTP-associated, NMDA receptor-mediated activation of adenylyl cyclase (5). We performed the experiment separately with Type I and Type II PKA holoenzymes as the exogenous kinase as the subunit dissociation characteristics for the two types differ (22) .
We found that the observed activity ratio of the stimulated tissue/exogenous kinase mixture coincided with the accurate prediction with both Type I PKA (Fig. 1B; 0 .286 Ϯ 0.010 observed versus 0.284 Ϯ 0.004 predicted; n ϭ 3) and Type II PKA (Fig. 1B; 0 .142 Ϯ 0.006 observed versus 0.143 Ϯ 0.008 predicted; n ϭ 6) as the exogenous kinase. In addition, the observed activity ratios were significantly different from the artifact prediction for both Type I (p Ͻ 0.05) and Type II (p Ͻ 0.01). Thus, PKA was not artifactually activated during homogenization. These results confirm that the assay accurately reflects in situ PKA activity and pave the way for using the assay to measure PKA activation in response to pharmacological and physiological stimuli.
PKA Activation by NMDA-Activation of the NMDA subtype of glutamate receptor is critical for the induction of LTP by 100-Hz tetani in area CA1 of the hippocampus (24) . We sought to extend our prior observation that NMDA receptor activation leads to activation of adenylyl cyclase (4, 5) and determine its effect on PKA. Bath application of 40 M NMDA for 5 min increased the PKA activity ratio in area CA1 ( Fig. 2A ; 224.9 Ϯ 12.2% of control, n ϭ 2, p Ͻ 0.0001); an increase in basal activity accounted for the change in activity ratio while total activity was not affected (data not shown). The effect of NMDA is receptor-mediated, as it was completely blocked by the NMDA receptor antagonist APV at 50 M ( Fig. 2A; 100 .0 Ϯ 12.6% of control, n ϭ 4) and because NMDA had no direct effect on PKA when included in the assay (data not shown). Stimulation of PKA by NMDA was concentration-dependent, with an EC 50 of approximately 36 M (Fig. 2B) , similar to that for the effect of NMDA on adenylyl cyclase (4, 5) . These results indicate that in area CA1 of the hippocampus, PKA is a downstream effector of NMDA receptor stimulation.
PKA Activation during LTP-Given the critical role of the NMDA receptor in LTP and evidence that NMDA receptor activation is coupled to increased PKA activity, we next asked whether in fact PKA is activated during LTP. We induced LTP with three sets of tetani spaced 10 min apart as described under "Experimental Procedures." This protocol reliably induced robust LTP lasting more than 3 h ( Fig. 3A ; average pEPSP slope 3 h after induction: 216.8 Ϯ 16.3% of baseline; n ϭ 8).
We began by examining the level of PKA activity 2 min after LTP was induced (all time points discussed are relative to the last set of tetani). At 2 min, the PKA activity ratio was significantly elevated ( Fig. 3B; 128 .2 Ϯ 10.0% of control; n ϭ 17, p Ͻ 0.005). As with unstimulated tissue (see above), the PKA inhibitor IP 20 completely blocked the kinase activity observed in LTP slices (data not shown), suggesting that the increased activity is not due to activation of a Kemptide-phosphorylating kinase other than PKA. These data indicate that LTP in area CA1 is associated with activation of PKA.
It is known that NMDA receptor activation is required for induction of this form of LTP (24) . Given the observed ability of NMDA receptor stimulation to induce PKA activation (Fig. 2) , we next asked whether NMDA receptors are required for the Forskolin was bath-applied to hippocampal slices at 50 M for 15 min, and area CA1 was microdissected and assayed as described under "Experimental Procedures" (n ϭ 4). Triple asterisks denote p Ͻ 0.0005 by unpaired t test. B, control for artifactual activation of PKA during homogenization. PKA activity in hippocampal slices was stimulated with 400 M NMDA for 3 min, and area CA1 was microdissected. The stimulated tissue was homogenized and assayed either alone or along with an excess amount of exogenous PKA having a low activity ratio (23) . Samples of the exogenous PKA alone were also assayed. The experiment was performed separately for Type I (n ϭ 3) and Type II PKA (n ϭ 6). If the activation of PKA observed in vitro were artifactual, then the exogenous kinase should be activated as well, and the mixture should have the same activity ratio as the stimulated tissue, designated Artifact Prediction. On the other hand, if the activation of PKA occurred in situ, not artifactually, then the exogenous kinase would not be activated, and the mixture should have an activity ratio equal to a weighted average of the endogenous and exogenous kinases' activity ratios, designated Accurate Prediction. The experimentally observed activity ratio for the mixture is designated Observation and equaled the second prediction with both forms of PKA, suggesting that artifactual activation of PKA upon homogenization does not occur. Statistical comparisons were made using the Tukey test following one-way analysis of variance; one asterisk denotes p Ͻ 0.05, and two denote p Ͻ 0.01.
LTP-associated increase in PKA activity. We delivered the repeated tetani with the NMDA receptor antagonist APV present in the bath at 50 M; under these conditions, LTP was not induced (data not shown). APV blocked the increase in PKA activity ratio at 2 min ( Fig. 3B ; 102.1 Ϯ 10.7% of control; n ϭ 8), indicating that NMDA receptor stimulation is required for the activation of PKA 2 min after LTP-inducing stimuli.
In our experiments, each LTP slice is compared to a control slice from the same preparation, frozen at the same time. We record briefly from control slices to ensure their viability, but they do not experience the repeated test stimuli which LTP slices receive in the course of assaying synaptic potentiation. Thus, it is a formal possibility that the activation of PKA during LTP is associated not with LTP per se but with the test stimuli. To address this question, we compared typical control slices to slices which received repeated test stimuli equivalent to that delivered to an LTP slice, but without the LTP-inducing tetanic stimulation. Test stimulation alone had no significant effect ( Fig. 3B ; 94.5 Ϯ 10.7% of control, n ϭ 10), and thus could not account for the activation of PKA associated with LTP.
As mentioned, in these experiments we induced LTP with a paradigm of repeated tetanization. LTP can also be induced by a single 1-s, 100-Hz tetanus; this paradigm produces a less robust potentiation which, in contrast to LTP induced by repeated tetani, is not blocked by PKA inhibitors (8) . To address whether these two paradigms in fact differentially activate PKA, we examined PKA activity 2 min after LTP was induced by a single tetanus. In contrast to our results with the repeated tetanus paradigm (Fig. 3) , we did not observe a significant change in the PKA activity ratio after a single tetanus (data not shown), although it is possible that some degree of PKA activation did occur that was below our threshold for detection. These data suggest that stronger LTP-inducing stimuli, which produce a higher magnitude of potentiation, are associated with greater activation of PKA; thus, the data are consistent with the hypothesis that PKA may function as a sort of volume control during LTP induction, regulating the degree of potentiation produced by a tetanic stimulus (see also Ref. 9) .
Time Course of PKA Activation during LTP-Some questions about the nature of PKA's role in LTP, such as whether its role is primarily in induction or in expression, could benefit from an awareness of the time course of PKA activation during LTP. We therefore next examined PKA activity at other time points Left, 40 M NMDA was bath-applied to hippocampal slices in otherwise normal recording saline for 5 min, area CA1 was microdissected and assayed as described under "Experimental Procedures" (n ϭ 4). Triple asterisks denote p Ͻ 0.0005 by unpaired t test. Right, the same experiment was performed, but with 50 M APV present in the bath prior to NMDA application (n ϭ 4). B, concentration dependence of NMDA's effect on PKA. NMDA was bathapplied at various concentrations to hippocampal slices for 5 min, and area CA1 was microdissected and assayed as described under "Experimental Procedures. "   FIG. 3 . Induction of LTP and activation of PKA. A, LTP physiology. After a 30-min baseline recording, 3 sets of tetanic stimuli were delivered, 10 min apart, as described under "Experimental Procedures." This paradigm resulted in a long-lasting, stable potentiation of the population excitatory postsynaptic potential (pEPSP) in area CA1, including both early and late phases of LTP. Top, extracellular field recordings from a representative experiment during baseline recording (a) and at 45 min (b) and 3 h (c) after LTP induction. Scale bar denotes 2 mV by 4 ms. Bottom, initial slope of the pEPSP, expressed as percent of the average baseline response, over time (n ϭ 8). Arrows represent the sets of tetani and lowercase letters refer to the times of the representative traces shown above. B, activation of PKA 2 min after LTP induction. PKA activity ratio is expressed as a percent of the activity ratio in control slices from the same preparation and frozen at the same time. Slices were frozen either 2 min after the final set of LTP-inducing tetanic stimuli (LTP, n ϭ 17), 2 min after delivery of the same stimulus but with 50 M DL-APV present in the bath (HFSϩAPV, n ϭ 8), or after an equivalent amount of 0.05-Hz test stimuli with no tetanic stimulation (Test Only, n ϭ 10). Area CA1 was microdissected and assayed as described under "Experimental Procedures." Double asterisks denote p Ͻ 0.01 by the Wilcoxin paired test. during LTP, again using the repeated tetanus paradigm. We found that PKA was not yet significantly activated at 1 min ( Fig. 4A ; 112.8 Ϯ 6.5% of control, n ϭ 16). However, the activation began by 2 min (see above) and, although reduced, was still significant at 10 min ( Fig. 4A; 114 .4 Ϯ 4.6% of control, n ϭ 12, p Ͻ 0.005). With an interest in whether PKA is persistently activated, we also examined PKA activity during the expression of both E-LTP and L-LTP. The PKA activity ratio was not significantly changed at either 45 min ( Fig. 4A ; 107.5 Ϯ 5.4% of control, n ϭ 14) or 3.5-5 h ( Fig. 4A; 86 .3 Ϯ 8.3% of control, n ϭ 8). These data indicate that activation of PKA begins within 2 min after LTP induction and is maintained for at least 10 min, but does not persist during E-LTP or L-LTP.
Examination of the two components of the activity ratio, basal activity and total activity, yields information pertinent to the mechanism of PKA activation during LTP. There is no change in total activity at any point during LTP (Fig. 4B) . This indicates that activation of PKA is not associated with changes in the amount of the enzyme or modification of its efficacy, as may be the case with PKC during LTP (25, 26) . All of the observed changes in PKA activity ratio are accounted for by changes in basal activity (Fig. 4B) . This is consistent with the expected effect of cyclic AMP; that is, dissociation of the catalytic subunit from the regulatory subunit increasing the proportion of PKA which is active without changing the enzymatic properties of the catalytic subunit per se. DISCUSSION We have demonstrated in these studies the development and use of an assay which enables the selective and accurate measurement of changes in PKA activity in hippocampal slices after various stimuli. Using this assay, we have shown that LTP is associated with transient activation of PKA that begins within 2 min, continues for at least 10 min, and decays by 45 min. The activation depends on NMDA receptor stimulation and does not involve any change in total PKA activity, consistent with mediation by cyclic AMP.
These results contribute to the emergence of a fairly clear picture of the pathway leading to activation of PKA during LTP in area CA1 of the hippocampus. It has been demonstrated that NMDA receptor activation triggers a rise in intracellular calcium, by permeation through either NMDA receptors themselves or voltage-gated calcium channels (27, 28) . We have shown that these NMDA receptors are coupled to activation of PKA. Previous studies indicated that this coupling is mediated by a calcium/calmodulin-dependent form of adenylyl cyclase (5) which is enriched in the hippocampus (29) . Dopamine receptors may also play a role in stimulating adenylyl cyclase (6) by activating G proteins which act synergistically with calcium/ calmodulin on adenylyl cyclase (30) . Adenylyl cyclase in turn produces a transient increase in cyclic AMP concentrations (4 -6); we have demonstrated with forskolin that such stimulation of adenylyl cyclase is sufficient to activate PKA in area CA1. Thus, during LTP, NMDA receptors initiate a cascade including calmodulin, perhaps dopamine receptor-stimulated G proteins, adenylyl cyclase, cyclic AMP, and eventually PKA.
The cellular and subcellular loci of these events are not well understood. PKA is present and physiologically active in both the soma and dendrites of postsynaptic hippocampal neurons as well as in presynaptic neurons (31) , and the biochemical studies in this and previous studies (4 -6) do not distinguish between events in the pre-and postsynaptic cells or between various compartments within each cell. There is, however, evidence that at least part of the LTP-associated activation of PKA occurs postsynaptically in the dendrites: LTP is associated with a transient, PKA-mediated suppression of the after hyperpolarization current (9) , and a recent study has indicated that the channels which carry this current are localized on the apical dendrites of CA1 pyramidal cells (32) . The activation of PKA during LTP, though, may not be limited to the dendrites. LTP-inducing stimuli do produce a large increase in somatic, as well as dendritic, calcium (28) , and somatic activation of PKA might be anticipated if part of PKA's role in L-LTP is to mediate changes in gene expression by phosphorylation of transcription factors (33) . There may also be an additional, presynaptic component of PKA activation during LTP.
The present study sheds light on the important subject of PKA's role in LTP induction versus its expression. It is known that nonspecific protein kinase inhibitors block both induction and expression of LTP (1); the observations that PKA can be persistently activated (10 -12) and that it modulates the glutamate receptors which support synaptic transmission (34, 35) suggested a means by which PKA could mediate LTP expression. However, our results demonstrate directly that PKA is not persistently activated in either E-LTP or L-LTP, but rather that the time course of its activation parallels changes in cyclic AMP concentrations (5), decaying to baseline levels between 10 and 45 min. Thus, PKA cannot underlie the expression of either phase. This is consistent with the observation that PKA inhibitors applied during E-LTP do not block its expression (8) . These results indicate that PKA's role in LTP must be in its induction, that is, in mediating or modulating the initiation of other mechanisms which in turn directly support the ongoing potentiation. The specific nature of PKA's role in LTP induction, though, is not clear. First, although the current inhibitor studies are not unequivocal, there seems to be a component of L-LTP induction that is quite sensitive to PKA inhibitors (6 -8) and a component of E-LTP induction that is perhaps less sensitive (6, 8, 9) . These data suggest that PKA may play distinct roles in these two phases. Second, the identity of PKA's substrates in the induction of these phases is an open question. Given the dependence of L-LTP on RNA and protein synthesis (36, 37) , interest in PKA's role in this phase has focused on phosphorylation of transcription factors, especially the cyclic AMP response element-binding protein (CREB). However, while CREB phosphorylation does occur during the induction of L-LTP (33, 38) , the phosphorylation appears to be mediated by CaMKII, not by PKA (38) . In E-LTP, it has been suggested that PKA permits or "gates" the induction of LTP by inhibiting phosphatases via phosphorylation of inhibitor-1 (9), although this hypothesis has not been directly tested.
A pathway has now been dissected beginning at the NMDA receptor, involving calcium/calmodulin, continuing through adenylyl cyclase, and leading to PKA. The challenge ahead is to continue the trek, moving down the cascade to begin to identify PKA's substrates in LTP.
